Clinical trials
Completed Observational Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
462 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 6 |
| 2005 | 9 |
| 2006 | 14 |
| 2007 | 9 |
| 2008 | 23 |
| 2009 | 16 |
| 2010 | 26 |
| 2011 | 7 |
| 2012 | 23 |
| 2013 | 15 |
| 2014 | 19 |
| 2015 | 19 |
| 2016 | 33 |
| 2017 | 37 |
| 2018 | 32 |
| 2019 | 33 |
| 2020 | 34 |
| 2021 | 26 |
| 2022 | 20 |
| 2023 | 15 |
| 2024 | 13 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 462 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 41 |
| Hoffmann-La Roche | 14 |
| Boehringer Ingelheim | 13 |
| Bristol-Myers Squibb | 13 |
| Alliance for Clinical Trials in Oncology | 12 |
| Pfizer | 11 |
| Hunan Province Tumor Hospital | 9 |
| M.D. Anderson Cancer Center | 9 |
| Maastricht Radiation Oncology | 8 |
| Intergroupe Francophone de Cancerologie Thoracique | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 462 |
| Lung Neoplasms | 118 |
| Small Cell Lung Carcinoma | 34 |
| Breast Neoplasms | 27 |
| Colonic Neoplasms | 18 |
| Colorectal Neoplasms | 17 |
| Neoplasms | 17 |
| Adenocarcinoma of Lung | 13 |
| Melanoma | 13 |
| Neoplasm Metastasis | 13 |
Trials
Showing 1 to 25 of 462. Each trial links to its page on Pharma Observatory.
362 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.